Onkologie. 2019:13(3):115-122 | DOI: 10.36290/xon.2019.023

Bone metastases: diagnosis and monitoring on imaging methods, interventional radiology

Jan Křístek1, Lukáš Pazourek2, Zdeněk Řehák3
1 Oddělení radiodiagnostiky, Masarykův onkologický ústav, Brno
2 I. ortopedická klinika, FN u sv. Anny, Brno
3 Oddělení nukleární medicíny, Masarykův onkologický ústav, Brno

Skeletal metastases in cancer patients are quite common (in 70 % of cases) and cause significant morbidity. Mostly they are asymptomatic,
but if they are not, they are a source of severe complications, pain and compromised quality of life. When metastasis
is suspected, the primary imaging modality in long bones and skull is the X-ray imaging. However, in the spine and pelvis, the
radiograph is often false negative and magnetic resonance imaging (MRI) is used. If this is not available, then computerized tomography
(CT) can be regarded as an option. If dissemination is suspected, scintigraphy, SPECT, or whole-body MR is the method
of choice. Expensive hybrid modalities, like positron emission tomography (PET-CT and PET-MR) are typically used in patients
already treated with clinical suspicion of dissemination. Biopsy (either percutaneous or peroperative) is only recommended if origin is unclear or additional histological, immunological or genetic testing is required. In the case of a known cancer diagnosis,
verification is usually not performed. When assessing the risk of pathological fracture, the location and nature of the lesion, pain,
bone destruction, and bone quality are assessed. The Mirels score can be used in long bones, Spinal Instability Neoplastic Score
(SIN score) is an alternative for spine lesions, which can give guidance on whether to perform surgical or other stabilization. In
solitary or oligometastatic disease (maximum of five foci under 3 cm), curative treatment in the form of radiotherapy, surgery or
some of the methods of interventional radiology, or a combination of all, can be considered an addition to the oncological treatment
itself. With more extensive disease, palliative therapy aims to maintain mobility and the highest possible quality of life for
the patient, to analgesize and prevent pathological fractures. In the case of painful lesions insufficiently responding to medication,
especially in the axial skeleton, the first choice is classic external radiotherapy or recently stereatactic radiation therapy. Surgical
solutions – splints, nailing, implantation of tumor endoprostheses, vertebral somatectomy with stabilization, resection, amputation
can be considered in indicated cases. From minimally invasive methods transarterial embolisation, percutaneous ablation
(radiofrequency, microwave, cryoablation, high-intensity focused ultrasound, cementoplasty, neurolysis, pharmacological blocks)
are used. The minimally invasive possibilities of interventional radiology are sometimes inadequately used in treatment of painful
conditions. Certainly, the treatment of patients in complex oncology centers with sufficient human and technical background
is advantageous. Indications for more advanced interventions should in principle be subject to discussion at multidisciplinary
boards in collaboration with an oncologist, orthopedic surgeon, surgeon, radiotherapist, diagnostic and interventional radiologist,
algesiologist, pathologist, or other specialist as appropriate.

Keywords: skeletal metastases, RTG, CT, MRI, diagnostic algorithm, interventional radiology

Published: May 24, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Křístek J, Pazourek L, Řehák Z. Bone metastases: diagnosis and monitoring on imaging methods, interventional radiology. Onkologie. 2019;13(3):115-122. doi: 10.36290/xon.2019.023.
Download citation

References

  1. https://radiopaedia.org/articles/skeletal-metastasis
  2. Willeumier JJ, van der Linden YM, van de Sande MAJ, et al. Treatment of pathological fractures of the long bones. EFORT Open Rev 2017; 1: 136-145. Go to original source... Go to PubMed...
  3. Harries M, Taylor A, Holmberg L, et al. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients. Cancer Epidemiol 2014; 38: 427-434. Go to original source... Go to PubMed...
  4. Shaaban AM, Blodgett TM, et al. Diagnostic Imaging. Oncology.1. vyd. Amirsys Publishing, 2013; 3/2-37.
  5. Fisher CG, Schouten R, Versteeg AL, et al. Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases Radiation Oncology 2014; 9: 69. http://www.ro-journal.com/content/9/1/69. Go to original source... Go to PubMed...
  6. Ratasvuori M, Wedin R, Keller J, et al. Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surg Oncol 2013; 22: 132-138. Go to original source... Go to PubMed...
  7. Healey JH. Metastatic cancer to the bone, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven, 1997: 2570-2586.
  8. Aboulafia AJ, Levine AM, Schmidt D, et al. Surgival Therapy of Bone Metastases. Semin. Oncol. 207; 34: 206-214.
  9. Szendrői M, Antal I, Szendrői A, et al. Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine. EFORT Open Rev. 2017 Sep 1; 2(9): 372-381. doi: 10.1302/2058-5241.2.170006.eCollection 2017 Sep. Go to original source... Go to PubMed...
  10. Attariwala R, Picker W. Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging. 2013 Aug; 38(2):253-68. doi: 10.1002/jmri.24285. Go to original source... Go to PubMed...
  11. Jehn CF, Ingo J, Overkamp F, et al. Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment. Anticancer Research. 2016; 36: 2631-2638. Go to PubMed...
  12. Web České radiologické společnosti: http://www.crs.cz/cs/certifikace-radiologickych-pracovist/mapa-pracovist.html
  13. Kawabata Y, Matsuo K, Nezu Y, et al. The risk assessment of pathological fracture in the proximal femur using a CT-based finite element method. J Orthop Sci. 2017 Sep; 22(5): 931-937. doi: 10.1016/j.jos.2017.05.015. Epub 2017 Jul 5. Go to original source... Go to PubMed...
  14. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 2010, 5: E1221-E1229. Go to original source... Go to PubMed...
  15. Lam TC, Uno H, Krishnan M, et al. Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy. Int J Radiat Oncol Biol Phys 2015;9 3: 373-381. Go to original source... Go to PubMed...
  16. Spratt DE, Beeler WH, de Moraes FY, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report.The Lancet Oncology, 2017; 18(12): e720-e730, December 2017. doi: 10.1016/S1470-2045(17)30612-5. Go to original source... Go to PubMed...
  17. Sahgal A, Atenafu EG, Chao S, et al. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 2013; 31: 3426-3431. Go to original source... Go to PubMed...
  18. Abdo J, Cornell DL, Mittal SK, et al. Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers. Front Oncol. 2018 Mar 28; 8: 85. doi: 10.3389/fonc.2018.00085.eCollection 2018. Go to original source... Go to PubMed...
  19. Takaki H, Cornelis F, Kako Y, et al. Thermal ablation and immunomodulation: From preclinical experiments to clinical trials. Diagn Interv Imaging. 2017 Sep; 98(9): 651-659. doi: 10.1016/j.diii.2017.04.008. Epub 2017 Jun 1. Go to original source... Go to PubMed...
  20. Garnon J, Koch G, Caudrelier J, et al. Expanding the borders: Image-guided procedures for the treatment of musculoskeletal tumors. Diagn Interv Imaging. 2017 Sep;98(9):635-644. doi: 10.1016/j.diii.2017.07.009. Epub 2017 Aug 23. Go to original source... Go to PubMed...
  21. Barile A, Arrigoni F, Zugaro L, et al. Minimally invasive treatments of painful bone lesions: state of the art. Med Oncol. 2017 Apr; 34(4): 53. doi: 10.1007/s12032-017-0909-2. Epub 2017 Feb 24. Go to original source... Go to PubMed...
  22. Ryška P, Řehák S, Odrážka K, et al. Role of percutaneous vertebroplasty and kyphoplasty in the threatment of onkology disorders of spine. Čas Lék Česk 2006; 145(10): 804-809. Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.